Europe - FRA:PFE - US7170811035 - Common Stock
We assign a fundamental rating of 5 out of 10 to PFE. PFE was compared to 49 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PFE while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on PFE.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.22% | ||
ROE | 12.12% | ||
ROIC | 7.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 28.52% | ||
PM (TTM) | 16.84% | ||
GM | 73.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 4.97 | ||
Altman-Z | 2.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.16 | ||
Quick Ratio | 0.85 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.07 | ||
Fwd PE | 7.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 10.97 | ||
EV/EBITDA | 6.98 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.92% |
FRA:PFE (9/19/2025, 5:28:40 PM)
20.3
-0.16 (-0.78%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.07 | ||
Fwd PE | 7.58 | ||
P/S | 2.14 | ||
P/FCF | 10.97 | ||
P/OCF | 8.98 | ||
P/B | 1.54 | ||
P/tB | N/A | ||
EV/EBITDA | 6.98 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.22% | ||
ROE | 12.12% | ||
ROCE | 10.81% | ||
ROIC | 7.61% | ||
ROICexc | 8.26% | ||
ROICexgc | 38.29% | ||
OM | 28.52% | ||
PM (TTM) | 16.84% | ||
GM | 73.96% | ||
FCFM | 19.48% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 4.97 | ||
Debt/EBITDA | 2.3 | ||
Cap/Depr | 40.51% | ||
Cap/Sales | 4.31% | ||
Interest Coverage | 5.77 | ||
Cash Conversion | 60.76% | ||
Profit Quality | 115.66% | ||
Current Ratio | 1.16 | ||
Quick Ratio | 0.85 | ||
Altman-Z | 2.14 |